stockrowLiquidia Corporation (LQDA) vs Indivior Pharmaceuticals Inc. (SUPN)
- Liquidia Corporation LQDA 44.69 −5.68%
- Indivior Pharmaceuticals Inc. SUPN 28.21 +0.21%
Liquidia Corporation and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Indivior Pharmaceuticals Inc. is the larger, with a market value of $5.6B against $4.0B — 1.4× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 7.6× against 28.5×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 16.4%. Indivior Pharmaceuticals Inc. has the higher net margin (32.9% vs 30.7%) and the higher return on invested capital (283.0% vs 121.1%). Across the 20 metrics below, Liquidia Corporation leads on 10 and Indivior Pharmaceuticals Inc. on 10.
Valuation
Profitability
| Metric | LQDA | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 92.54% | 84.85% | 53.51% |
| Operating margin | 37.39% | 40.57% | 0.00% |
| Net margin | 30.74% | 32.85% | (2.45%) |
| Free cash flow margin | 33.42% | 2.26% | 0.00% |
| Return on equity | 131.82% | (337.83%) | (0.80%) |
| Return on assets | 35.57% | 32.82% | (1.67%) |
| Return on invested capital | 121.05% | 283.03% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack